Jaguar Health (JAGX) Assets Average (2015 - 2026)
Jaguar Health (JAGX) posted quarterly Assets Average of $20.7 million for Q1 2026, down 60.5% year-over-year from $52.4 million in Q1 2025, and down 22.51% quarter-over-quarter from $26.7 million in Q4 2025.
Jaguar Health (JAGX) Assets Average (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Assets Average for 12 consecutive years, with $20.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 60.5% year-over-year to $20.7 million; the TTM figure through Mar 2026 stood at $20.7 million (down 60.5% YoY), while the FY2025 annual figure was $28.7 million, down 44.88% from the prior year.
- Assets Average eased to $20.7 million in Q1 2026 per JAGX's latest filing, from $26.7 million in the prior quarter.
- Across five years, Assets Average topped out at $60.0 million in Q3 2024 and bottomed at $20.7 million in Q1 2026.
- Historically, Assets Average has averaged $49.1 million across 5 years, with a median of $51.4 million in 2022.
- Annual changes were most pronounced in 2024 — Assets Average gained 22.93% — and 2026, when it plunged 60.5%.
- Jaguar Health's Assets Average stood at $49.4 million in 2022, then retreated by 2.63% to $48.1 million in 2023, then increased by 16.38% to $55.9 million in 2024, then sank by 52.21% to $26.7 million in 2025, then fell by 22.51% to $20.7 million in 2026.
- Business Quant data shows JAGX's Assets Average at $20.7 million in Q1 2026, $26.7 million in Q4 2025, and $48.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Jaguar Health | 452,552.38 | -9.61 Mn | 19.11 Mn | 20.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.72 Mn |
| Dec 31, 2025 | 26.74 Mn |
| Sep 30, 2025 | 48.87 Mn |
| Jun 30, 2025 | 49.86 Mn |
| Mar 31, 2025 | 52.44 Mn |
| Dec 31, 2024 | 55.95 Mn |
| Sep 30, 2024 | 59.96 Mn |
| Jun 30, 2024 | 58.42 Mn |
| Mar 31, 2024 | 53.08 Mn |
| Dec 31, 2023 | 48.07 Mn |
| Sep 30, 2023 | 48.78 Mn |
| Jun 30, 2023 | 54.55 Mn |
| Mar 31, 2023 | 52.19 Mn |
| Dec 31, 2022 | 49.37 Mn |
| Sep 30, 2022 | 50.59 Mn |
| Jun 30, 2022 | 51.40 Mn |
| Mar 31, 2022 | 53.09 Mn |
| Dec 31, 2021 | 56.26 Mn |
| Sep 30, 2021 | 64.40 Mn |
| Jun 30, 2021 | 69.13 Mn |